Product Information
GNP MUCUS RLF DM 20-400 MG TAB is a generic product labeled by AmerisourceBergen, priced at $0.0819 per EA under NDC 46122079061. Its NADAC has been published 82 times since Mar 12, 2025.
Strength
20; 400 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122079061
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/23/2024
Pharmacological Classes
Price Statistics
The NADAC for GNP MUCUS RLF DM 20-400 MG TAB has been published 82 times since Mar 12, 2025, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0819 per EA |
|---|---|
| All-time high | $0.0819 (Sep 30, 2026) |
| All-time low | $0.0771 (Jun 18, 2025) |
| 52-week high | $0.0819 |
| 52-week low | $0.0779 |
| Median price | $0.0787 |
| Average price | $0.0786 |
| Largest weekly change | +3.1% (Sep 23, 2026) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP MUCUS RLF DM 20-400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GNP MUCUS RLF DM 20-400 MG TAB, manufactured by AmerisourceBergen, is $0.0819 per EA (NDC 46122079061), effective Sep 30, 2026.
How has the price of GNP MUCUS RLF DM 20-400 MG TAB changed over time?
Over the history we have for it, the NADAC for GNP MUCUS RLF DM 20-400 MG TAB has risen 5.7%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for GNP MUCUS RLF DM 20-400 MG TAB?
Since Mar 12, 2025, the NADAC for GNP MUCUS RLF DM 20-400 MG TAB has ranged from a low of $0.0771 (Jun 18, 2025) to a high of $0.0819 (Sep 30, 2026), with a median of $0.0787 per EA.
Are there cheaper alternatives to GNP MUCUS RLF DM 20-400 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of GNP MUCUS RLF DM 20-400 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP MUCUS RLF DM 20-400 MG TAB?
GNP MUCUS RLF DM 20-400 MG TAB (NDC 46122079061) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.